Marex Group

MRX · NASDAQ

$69.96+$1.42 (+2.07%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $68.54

MRX analyst rating

BuyConsensus of 8 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy8
Hold0
Underperform0
Sell0

12-month price target · 9 analysts

Average $83.51 (+19.4% upside)

Low: $36.36
Now: $69.96
High: $105.00

Upgrades and downgrades

The latest rating actions, newest first

MRX analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
William Blair	Oct 14, 2026	Initiates	Outperform	—	67%
Barclays	Oct 7, 2026	Maintains	Overweight	$86.00 → $92.00	57%
Piper Sandler	Oct 2, 2026	Maintains	Overweight	$75.00 → $80.00	62%
UBS	Aug 13, 2026	Maintains	Buy	$82.00 → $90.00	63%
Barclays	Aug 13, 2026	Maintains	Overweight	$76.00 → $86.00	57%
Keefe, Bruyette & Woods	Aug 13, 2026	Maintains	Outperform	$80.00 → $90.00	57%
Jefferies	Jul 20, 2026	Maintains	Buy	$57.00 → $80.00	66%
Piper Sandler	Jul 15, 2026	Maintains	Overweight	$55.00 → $75.00	62%
Keefe, Bruyette & Woods	Jul 10, 2026	Maintains	Outperform	$60.00 → $80.00	57%
Barclays	Jul 9, 2026	Maintains	Overweight	$60.00 → $76.00	57%

The case for and against

Updated Oct 31, 2025

Bull case

Marex Group PLC is poised for strong organic growth driven by share gains in its core markets, new product launches, and geographical expansion, supported by solid momentum in commodity and energy trading. The company has raised its earnings expectations for 2025, particularly due to higher revenue estimates from its Agency and Execution segment following a strong quarterly performance. Additionally, Marex anticipates further growth opportunities from its clearing business pipeline, which could further enhance its financial position in the future.

Bear case

Marex Group PLC faces a challenging outlook primarily due to its sensitivity to interest rates, which is anticipated to create headwinds for revenue and profit growth over the forecast period. Additionally, the liquidity overhang stemming from private equity ownership following the IPO raises concerns about the financial stability and operational flexibility of the firm. These factors, coupled with the expected deceleration in growth rates from recent strong performance, contribute to a negative outlook on the company's stock.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.